Alcon AG | ALC - Net Income

Stock Price
61.34
Daily Change
-0.08 -0.13%
Monthly
-5.95%
Yearly
-26.61%
Q1 Forecast
60.90

Alcon AG reported $237M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AstraZeneca USD 2.53B 83M Sep/2025
Bayer EUR -963M 764M Sep/2025
Essilor EUR 1.39B 890M Jun/2025
Fresenius EUR 344M 14M Sep/2025
Fresenius Medical Care EUR 274.8M 49.8M Sep/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 126.96M 9.9M Sep/2025
Lonza CHF 307M 22M Dec/2024
Merck EUR 902M 250M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Philips EUR 184M 56M Sep/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Smith & Nephew USD 293M 79M Dec/2025
Sonova Holding CHF 188.5M 143.4M Dec/2025
UCB EUR 857M 649M Dec/2024